Figure 1.
Left: Non-immunogenic “cold” tumor characterized by M2 macrophage polarization, upregulation of vascular endothelial growth factor (VEGF), regulatory T cell (Tregs), downregulation of tumor antigen cross-presentation and tumor infiltrating lymphocyte (TIL) count. Right: Immunogenic “Hot” tumor characterized by M1 macrophage polarization, upregulation of tumor antigen presentation and TIL count, and downregulation of VEGF, Tregs and other immunosuppressive factors.